Keywords: bi, 1st-half, sales, up, privately-owned, german, drug
BI 1st-half sales up 7%
Article | 23 August 2004
Privately-owned German drug major Boehringer Ingelheim posted a 7% risein first-half 2004 sales to 3.7 billion euros ($4.57 billion) and a 25% increase in operating ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
